Subcutaneous Interferon beta therapy in multiple sclerosis patients and characterization of injection site reactions and flu-like symptoms under daily practice setting (PERFECT)

22/11/2017
02/04/2024
EU PAS number:
EUPAS21013
Study
Finalised
Documents
Study protocol
Study results
Study results
English (267.14 KB - PDF) View document
Study report
Other information